Atlas Trials

An Observational Study for Analysis of Mortality in Participants Who Participated in Previous 3 Studies of Galantamine

Clinical trial NCT00297414 · COMPLETED

Trial details

NCT number
NCT00297414
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Status
COMPLETED
Study type
OBSERVATIONAL
Mild Cognitive Impairment
Start date
2004-06-01
Primary completion
2005-01-01
Enrollment
1083

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.